{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:17:52Z","timestamp":1786979872564,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Key Research and Development Plan project of Shandong","award":["2018GCF118137"],"award-info":[{"award-number":["2018GCF118137"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00253-021-11682-4","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T03:03:01Z","timestamp":1638414181000},"page":"185-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The inhibitory effect of rBCG on EB virus-positive tumours using an EB virus fusion gene"],"prefix":"10.1007","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5561-4091","authenticated-orcid":false,"given":"Qing-jie","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-xia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"issue":"2","key":"11682_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/ijc.20594","volume":"113","author":"F Chen","year":"2005","unstructured":"Chen F, Liu C, Lindvall C, Xu D, Ernberg I (2005) Epstein-Barr virus latent membrane ZA(LMP2A)down reg\u03bclates telomerase reverse transeriptase (hTERT) irepithelialcell lines. Int J Caneer 113(2):284\u2013289. https:\/\/doi.org\/10.1002\/ijc.20594","journal-title":"Int J Caneer"},{"key":"11682_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.virusres.2007.03.016","volume":"127","author":"VA Govan","year":"2007","unstructured":"Govan VA, Williamson A-L (2007) Rabbits immunised with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L2E7E2 genes induces regression of established papillomas. Virus Res 127:43\u201348. https:\/\/doi.org\/10.1016\/j.virusres.2007.03.016","journal-title":"Virus Res"},{"issue":"8","key":"11682_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s13238-010-0095-x","volume":"1","author":"T Hayashi","year":"2010","unstructured":"Hayashi T, Horiuchi A, Sano K, Hiraoka N, Kanai Y, Shiozawa T, Tonegawa S, Konishi I (2010) Mice-lacking LMP2, immuno-proteasome subunit, as an animal model of spontaneous uterine leiomyosarcoma. Protein Cell 1(8):711\u2013717. https:\/\/doi.org\/10.1007\/s13238-010-0095-x","journal-title":"Protein Cell"},{"key":"11682_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/fimmu.2018.00643","volume":"9","author":"BJ Kim","year":"2018","unstructured":"Kim BJ, Kim BR, Kook YH, Kim BJ (2018) Development of a live recombinant BCG expressing human immunodeficiency virus type 1 (HIV-1) gag using a pMyong 2 vector system: potential use as a novel HIV-1 vaccine. Front Immunol 9:643. https:\/\/doi.org\/10.3389\/fimmu.2018.00643","journal-title":"Front Immunol"},{"issue":"1","key":"11682_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1128\/jvi.77.1.199-207.2003","volume":"77","author":"RJ Kraus","year":"2003","unstructured":"Kraus RJ, Perrigoue JG, Mertz JE (2003) ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus. J Virol 77(1):199\u2013207. https:\/\/doi.org\/10.1128\/jvi.77.1.199-207.2003","journal-title":"J Virol"},{"key":"11682_CR6","doi-asserted-by":"publisher","unstructured":"Luo Y, Yamada H, Chen X (2004) Recombinant. Clin Exp Immunol 137(1):24\u201334.\u00a0https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02522.x","DOI":"10.1111\/j.1365-2249.2004.02522.x"},{"key":"11682_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577166","volume":"339","author":"SB Marcucci","year":"2020","unstructured":"Marcucci SB, Obeidat AZ (2020) EBNA1, EBNA2, and EBNA3 link Epstein-Barr virus and hypovitaminosis D in multiple sclerosis pathogenesis. J Neuroimmunol 339:577116. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577166","journal-title":"J Neuroimmunol"},{"issue":"6","key":"11682_CR8","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s11262-019-01705-8","volume":"55","author":"J Needham","year":"2019","unstructured":"Needham J, Adamson AL (2019) BZLF1 transcript variants in Epstein-Barr virus-positive epithelial cell lines. Virus Genes 55(6):779\u2013785. https:\/\/doi.org\/10.1007\/s11262-019-01705-8","journal-title":"Virus Genes"},{"issue":"1","key":"11682_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1128\/JVI.77.1.105-114.2003","volume":"77","author":"T Portis","year":"2003","unstructured":"Portis T, Longneeker R (2003) Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphoeyte development. J Virol 77(1):105\u2013114. https:\/\/doi.org\/10.1128\/JVI.77.1.105-114.2003","journal-title":"J Virol"},{"issue":"3\/4","key":"11682_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10555-009-9195-6","volume":"28","author":"HM Rosevear","year":"2009","unstructured":"Rosevear HM, Lightfoot AJ, O\u2019Donnell MA, Griffith TS (2009) The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guerin (BCG) immunotherapy for urothelial carcinoma of the bladder. Cancer Metastasis Rev 28(3\/4):345\u2013353. https:\/\/doi.org\/10.1007\/s10555-009-9195-6","journal-title":"Cancer Metastasis Rev"},{"key":"11682_CR11","doi-asserted-by":"publisher","unstructured":"Smith C, Tsang J, Beagley L, Chua D, Lee V, Li V, Moss DJ, Coman W, Chan KH, Nicholls J (2012) Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy. Cancer Res 72(5):1116\u20131125.\u00a0https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3399","DOI":"10.1158\/0008-5472.CAN-11-3399"},{"issue":"6326","key":"11682_CR12","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/351456a0","volume":"351","author":"CK Stover","year":"1991","unstructured":"Stover CK, Dela CVF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, Bansal GP, Young JF, Lee MH, Hatfull GF (1991) New use of BCG for recombinant vaccines. Nature 351(6326):456\u2013460. https:\/\/doi.org\/10.1038\/351456a0","journal-title":"Nature"},{"issue":"19","key":"11682_CR13","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1158\/1078-0432.CCR-14-1122-T","volume":"20","author":"GS Taylor","year":"2014","unstructured":"Taylor GS, Jia H, Harrington K, Lee LW, Turner J, Ladell K, Price DA, Tanday M, Matthews J, Roberts C, Edwards C, Mcguigan L, Hartley A, Wilson S, Hui EP, Chan ATC, Rickinson AB, Steven NM (2014) A recombinant modified vaccinia Ankara vaccine encoding Epstein-Barr virus ( EBV) target antigens: a phase I trial in UK patients with EBV positive cancer. Clin Cancer Res 20(19):5009\u20135022. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-1122-T","journal-title":"Clin Cancer Res"},{"issue":"12","key":"11682_CR14","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.vaccine.2017.02.024","volume":"35","author":"QJ Xue","year":"2017","unstructured":"Xue QJ, Li YQ, Yang CQ, Chen T, Li XZ, Cheng B, Wang CM (2017) Anti-tumour research of recombinant BCG using BZLF1 and hGM-CSF fusion genes. Vaccine 35(12):1599\u20131607. https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.024","journal-title":"Vaccine"},{"key":"11682_CR15","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3389\/fonc.2019.01391","volume":"9","author":"G Zhang","year":"2019","unstructured":"Zhang G, Li Z, Zhou Q (2019) Utility of serum EB virus Zta antibody in the diagnostic of nasopharyngeal carcinoma: evidences from 2,126 cases and 15,644 controls. Front Oncol 9:1391. https:\/\/doi.org\/10.3389\/fonc.2019.01391","journal-title":"Front Oncol"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-021-11682-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-021-11682-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-021-11682-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T13:03:34Z","timestamp":1640955814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-021-11682-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["11682"],"URL":"https:\/\/doi.org\/10.1007\/s00253-021-11682-4","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"9 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving mice were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All animal experiments were approved by the Shandong animal experimentation committees (2009\u20130023; approval date, 2\/25\/09\u20133\/25\/14).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}